Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus
- PMID: 25338677
- PMCID: PMC4305028
- DOI: 10.1038/gene.2014.57
Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by inflammation of multiple organ systems and dysregulated interferon responses. SLE is both genetically and phenotypically heterogeneous, greatly reducing the power of case-control studies in SLE. Elevated circulating interferon-alpha (IFN-α) is a stable, heritable trait in SLE, which has been implicated in primary disease pathogenesis. About 40-50% of patients have high IFN-α, and high levels correspond with clinical differences. To study genetic heterogeneity in SLE, we performed a case-case study comparing patients with high vs low IFN-α in over 1550 SLE cases, including genome-wide association study and replication cohorts. In meta-analysis, the top associations in European ancestry were protein kinase, cyclic GMP-dependent, type I (PRKG1) rs7897633 (P(Meta) = 2.75 × 10(-8)) and purine nucleoside phosphorylase (PNP) rs1049564 (P(Meta) = 1.24 × 10(-7)). We also found evidence for cross-ancestral background associations with the ankyrin repeat domain 44 (ANKRD44) and pleckstrin homology domain containing, family F member 2 gene (PLEKHF2) loci. These loci have not been previously identified in case-control SLE genetic studies. Bioinformatic analyses implicated these loci functionally in dendritic cells and natural killer cells, both of which are involved in IFN-α production in SLE. As case-control studies of heterogeneous diseases reach a limit of feasibility with respect to subject number and detectable effect size, the study of informative pathogenic sub-phenotypes becomes an attractive strategy for genetic discovery in complex disease.
Figures
References
-
- Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol. 2006;28(2):119–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P20 RR020143/RR/NCRR NIH HHS/United States
- AR053308/AR/NIAMS NIH HHS/United States
- UL1 RR024999/RR/NCRR NIH HHS/United States
- K08 AI083790/AI/NIAID NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- AR042460/AR/NIAMS NIH HHS/United States
- AI071651/AI/NIAID NIH HHS/United States
- R01 CA141700/CA/NCI NIH HHS/United States
- I01 BX001834/BX/BLRD VA/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- R01 AR043274/AR/NIAMS NIH HHS/United States
- N01 AR62277/AR/NIAMS NIH HHS/United States
- P60 AR053308/AR/NIAMS NIH HHS/United States
- R01 DE018209/DE/NIDCR NIH HHS/United States
- N01 AR062277/AR/NIAMS NIH HHS/United States
- RC1 AR058621/AR/NIAMS NIH HHS/United States
- R01 AR043814/AR/NIAMS NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- L30 AI071651/AI/NIAID NIH HHS/United States
- R01 AR43814/AR/NIAMS NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- R01 AR060861/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
